133 related articles for article (PubMed ID: 17433265)
1. Poly(ADP-ribose) polymerase inhibition by cilostazol is implicated in the neuroprotective effect against focal cerebral ischemic infarct in rat.
Lee JH; Park SY; Shin HK; Kim CD; Lee WS; Hong KW
Brain Res; 2007 Jun; 1152():182-90. PubMed ID: 17433265
[TBL] [Abstract][Full Text] [Related]
2. Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats.
Park SY; Lee JH; Kim CD; Rhim BY; Hong KW; Lee WS
Brain Res; 2007 Jul; 1157():112-20. PubMed ID: 17521620
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
Kabra DG; Thiyagarajan M; Kaul CL; Sharma SS
Brain Res Bull; 2004 Feb; 62(5):425-33. PubMed ID: 15168908
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of scutellarin against cerebral ischemia in rats: evidence for inhibition of the apoptosis-inducing factor pathway.
Zhang HF; Hu XM; Wang LX; Xu SQ; Zeng FD
Planta Med; 2009 Feb; 75(2):121-6. PubMed ID: 19031363
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate alleviates neuronal cell damage against focal cerebral ischemia in rats.
Park DJ; Kang JB; Koh PO
J Vet Med Sci; 2020 May; 82(5):639-645. PubMed ID: 32224555
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribose) polymerase inhibition protect neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke.
Komjáti K; Mabley JG; Virág L; Southan GJ; Salzman AL; Szabó C
Int J Mol Med; 2004 Mar; 13(3):373-82. PubMed ID: 14767566
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
Singh N; Sharma G; Singh N; Hanif K
Int J Stroke; 2014 Jul; 9(5):560-8. PubMed ID: 23013350
[TBL] [Abstract][Full Text] [Related]
8. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment.
Ding Y; Zhou Y; Lai Q; Li J; Gordon V; Diaz FG
Brain Res; 2001 Oct; 915(2):210-7. PubMed ID: 11595210
[TBL] [Abstract][Full Text] [Related]
9. Involvement of PARP-1/AIF Signaling Pathway in Protective Effects of Gualou Guizhi Decoction Against Ischemia-Reperfusion Injury-Induced Apoptosis.
Nan L; Xie Q; Chen Z; Zhang Y; Chen Y; Li H; Lai W; Chen Y; Huang M
Neurochem Res; 2020 Feb; 45(2):278-294. PubMed ID: 31792665
[TBL] [Abstract][Full Text] [Related]
10. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
11. Cerebral endothelial cell apoptosis after ischemia-reperfusion: role of PARP activation and AIF translocation.
Zhang Y; Zhang X; Park TS; Gidday JM
J Cereb Blood Flow Metab; 2005 Jul; 25(7):868-77. PubMed ID: 15729291
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rd blocks AIF mitochondrio-nuclear translocation and NF-κB nuclear accumulation by inhibiting poly(ADP-ribose) polymerase-1 after focal cerebral ischemia in rats.
Hu G; Wu Z; Yang F; Zhao H; Liu X; Deng Y; Shi M; Zhao G
Neurol Sci; 2013 Dec; 34(12):2101-6. PubMed ID: 23463404
[TBL] [Abstract][Full Text] [Related]
13. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
14. Effect of cilostazol pretreatment on the PARP/AIF-mediated apoptotic pathway in rat cerebral ischemia-reperfusion models.
Ba XH; Cai LP; Han W
Exp Ther Med; 2014 May; 7(5):1209-1214. PubMed ID: 24940413
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia.
Egi Y; Matsuura S; Maruyama T; Fujio M; Yuki S; Akira T
Brain Res; 2011 May; 1389():169-76. PubMed ID: 21420942
[TBL] [Abstract][Full Text] [Related]
16. An oral administration of cilostazol before focal ischemia reduces the infarct volume with delayed cerebral blood flow increase in rats.
Yuzawa I; Yamada M; Fujii K
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):281-6. PubMed ID: 18755408
[TBL] [Abstract][Full Text] [Related]
17. The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals.
Koh SH; Park Y; Song CW; Kim JG; Kim K; Kim J; Kim MH; Lee SR; Kim DW; Yu HJ; Chang DI; Hwang SJ; Kim SH
Eur J Neurosci; 2004 Sep; 20(6):1461-72. PubMed ID: 15355313
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase.
Moroni F; Cozzi A; Chiarugi A; Formentini L; Camaioni E; Pellegrini-Giampietro DE; Chen Y; Liang S; Zaleska MM; Gonzales C; Wood A; Pellicciari R
Br J Pharmacol; 2012 Mar; 165(5):1487-500. PubMed ID: 21913897
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats.
Choi JM; Shin HK; Kim KY; Lee JH; Hong KW
J Pharmacol Exp Ther; 2002 Mar; 300(3):787-93. PubMed ID: 11861782
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation.
Kaundal RK; Shah KK; Sharma SS
Life Sci; 2006 Nov; 79(24):2293-302. PubMed ID: 16935310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
